Name: UMIN ID:
Unique ID issued by UMIN | UMIN000037727 |
---|---|
Receipt number | R000043026 |
Scientific Title | Real world evidence of PD-L1, TMB prevalence and efficacy of 1st line chemotherapy in these high or low population for stage IV urothelial cancer |
Date of disclosure of the study information | 2019/09/01 |
Last modified on | 2021/03/31 17:44:34 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/08/19 13:32:28 | ||
2 | Update | 2019/09/11 13:31:29 | Institutions |
|
3 | Update | 2019/10/02 10:03:37 | Institutions |
|
4 | Update | 2019/10/28 13:23:57 | Institutions |
|
5 | Update | 2019/10/28 16:03:15 | Recruitment status Date of IRB |
|
6 | Update | 2019/11/28 10:06:41 | Institutions |
|
7 | Update | 2020/02/07 18:19:38 | Institutions |
|
8 | Update | 2020/02/26 10:36:06 | Last follow-up date Date of closure to data entry Other related information Other related information |
|
9 | Update | 2020/03/30 13:43:27 | Recruitment status |
|
10 | Update | 2020/05/07 17:27:06 | Basic objectives -Others Basic objectives -Others Key secondary outcomes Key secondary outcomes |
|
11 | Update | 2020/05/07 17:30:43 | Date trial data considered complete Other related information Other related information |
|
12 | Update | 2020/05/26 11:38:58 | Key secondary outcomes |
|
13 | Update | 2021/01/25 12:06:43 | Recruitment status |
|
14 | Update | 2021/03/31 10:45:59 | Institutions |
|
15 | Update | 2021/03/31 10:48:17 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
16 | Update | 2021/03/31 17:42:30 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
17 | Update | 2021/03/31 17:44:34 | Name of person sending information Name of person sending information Address Address TEL |